CVM · Cel-Sci Corp
United States · RS rating 48 · As of 2026-10-14
| Price | 1.71 USD |
|---|---|
| 1-day change | -2.3% |
| RS rating (overall / 1M / 3M / 12M) | 48 / 96 / 96 / 5 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 16 / 15 / 23 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +1.5% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +83.1% |
| Market cap (USD) | $28.0M |